A lymphokine-activated killer (LAK)-resistant cell line, and low expression of adhesion molecules LFA-3 and VCAM-1 on its cell surface

Oncology Research

Volumn 10, Issue 5, 1998, Pages 263-269

  Komatsu, Fumio ^a   Kajiwara, Michiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adhesion molecules; Antibody dependent cell mediated cytotoxicity (ADCC); CD86; LAK resistant cell line; LFA 3; VCAM 1

Indexed keywords

GAMMA INTERFERON; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL CULTURE; CYTOTOXICITY; HUMAN; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; METABOLISM; PHYSIOLOGY; T CELL LEUKEMIA;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD58; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON TYPE II; KILLER CELLS, LYMPHOKINE-ACTIVATED; LEUKEMIA, T-CELL; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032246810     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Storkus, W. J.; Howell, D. N.; Salter, R. D.; Dawson, J. R.; Cresswell, E. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138:1657-1659; 1987.
2. Moretta, A.; Tambussi, G.; Bottino, C.; Tripodi, G.; Merli, A.; Ciccone, E.; Pantaleo, G.; Moretta, L. A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells: Role in cell activation and regulation of cytolytic function. J. Exp. Med. 171:695-714; 1990.
3. Ljunggren, H-G.; Karre, K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11:237-244; 1990.
4. Berke, G. The CTL's kiss of death. Cell 81:9-12; 1995.
5. + T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med. 175:895-905; 1992.
6. Carbone, E.; Ruggiero, G.; Terrazzano, G.; Palomba, C.; Manzo, C.; Fontana, S.; Spits, H.; Karre, K.; Zappacosta, S. A new mechanism of NK cell cytotoxicily activation: The CD40-CD40 ligand interaction. J. Exp. Med. 185:2053-2060; 1997.
7. Garcia-Barcina, M.; Bidaurrazaga, I.; Neaud, V.; Bioulac-Sage, P.; Balabaud, C.; Vidal-Vanaclocha, F.; Winnock, M. Variations in the expression of cell-adhesion molecules on liver-associated lymphocytes and peripheral-blood lymphocytes in patients with and without liver metastasis. Int. J. Cancer 61:475-479; 1995.
8. Pinola, M.; Saksela, E.; Tiisala, S.; Renkonen, R. Human NK cells expressine α4 β1/β7 adhere to VCAM-1 without preactivation. Scand. J. Immunol. 39:131-136; 1994.
9. Takahashi, K.; Nakamura, T.; Koyanagi, M.; Kato, K.; Hashimoto, Y.; Yagita, H.; Okumura, K. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction. J. Immunol. 145:4371-4379; 1990.
10. Osborn, L.; Day, E. S.; Miller, G. T.; Karpusas, M.; Tizard, R.; Meuer, S. C.; Hochman, P. S. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2. J. Exp. Med. 181:429-434; 1995.
11. Komatsu, F.; Tamiya, H. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines. Oncol. Res. 10:59-67; 1998.
12. Gollob, J. A.; Li, J.; Kawasaki, H.; Daley, J. F.; Groves, C.; Reinherz, E. L.; Ritz, J. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J. Immunol. 157:1886-1893; 1996.
13. Gwin, J. L.; Gercel-Taylor, C.; Taylor, D. D.; Eisenberg, R. Role of LFA-3, ICAM-1, and MHC class1 on the sensitivity of human tumor cells to LAK cells. J. Surg. Res. 60:129-136; 1996.
14. Shaw, S.; Luce, G. E. G. The lymphocyte function-associated antigen (LFA)-l and CD2/LFA-3 pathways of antigen-independent human T cell adhesion. J. Immunol. 139:1037-1045; 1987.
15. Hoshino, T.; Yamada, A.; Honda, J.; Imai, Y.; Nakao, M.; Inoue, M.; Sagawa, K.; Yokoyama, M. M.; Oizumi, K.; Itoh, K. Tissue-specific distribution and age-dependent increase of human GD11b+T cells. J. Immunol. 151:2237-2246; 1993.
16. Van de Wiel-van Kemenade, E.; Te Velde, A. A.; De Boer, A. J.; Weening, R. S.; Fischer, A.; Borst, J.; Melief, C. J. M.; Figdor, C. G. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation. Eur. J. Immunol. 22:1467-1475; 1992.
17. Fogler, W. E.; Volker, K.; McCormick, K. L.; Watanabe, M.; Ortaldo, J. R.; Wiltrout, R. H. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707-4714; 1996.
18. Freeman, G. J.; Borriello, F.; Hodes, R. J.; Reiser, H.; Hathcock, K. S.; Laszlo, G.; McKnight, A. J.; Kim, J.; Du, L.; Lombard, D. B.; Gray, G. S.; Nadler, L. M.; Sharpe, A. H. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907-909; 1993.
19. Lee, K. P.; Thompson, C. B.; Griesser, H.; Mak, T. W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988; 1995.
20. Sonoda, S.; Yashiki, S.; Takahashi, K.; Arima, N.; Daitoku, Y.; Matsumoto, M.; Tadashi, M.; Tara, M.; Shinmyozu, K.; Sato, K.; Inoko, H.; Ando, A.; Tsuji, K. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives. Int. J. Cancer 40:629-634; 1987.